Advertisement

Physiopathology, Diagnosis, and Treatment of GH Deficiency

  • Fatih Tanriverdi
  • Fahrettin Kelestimur
Reference work entry
Part of the Endocrinology book series (ENDOCR)

Abstract

Growth hormone deficiency (GHD) in adults arises due to decreased secretion of GH from the pituitary gland. Until two decades ago, GHD in adults was not accepted as a clinical syndrome, and it was supposed that GH has little physiologic effects after adolescence. However after the advent of recombinant GH, physiologic role of GH becomes clearer in the adult life, and the studies during the last two decades revealed GHD as a real disease associated with a plenty of clinical manifestations. GHD is one of the most common hormonal deficiencies in adults with hypopituitarism due to variety of causes. In the present chapter, acquired causes, pathophysiology, diagnosis, and treatment of GHD in adults will be discussed based on the recent advances in the literature.

Keywords

Growth hormone deficiency (GHD) Growth hormone replacement therapy (GHRT) Hypopituitarism Recombinant GH (rhGH) Traumatic brain injury (TBI) Sheehan’s syndrome Pituitary Hypothalamus 

References

  1. Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, Wuster C. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol. 1999;50:703.CrossRefGoogle Scholar
  2. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J, Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm IGF Res. 2005;15:349.PubMedCrossRefGoogle Scholar
  3. Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI, Wilton P, Koltowska-Haggstrom M. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysis. Eur J Endocrinol. 2006;155:79.PubMedCrossRefGoogle Scholar
  4. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab. 1998;83:1615.PubMedGoogle Scholar
  5. Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Toft SH, Stochholm K, Strasburger C, Swerdlow A, Thorner M. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2016;174:1.CrossRefGoogle Scholar
  6. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastella A. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab. 1993;77:1671.PubMedGoogle Scholar
  7. Appelman-Dijkstra NM, Claessen KM, Roelfsema F, Pereira AM, Biermasz NR. Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review. Eur J Endocrinol. 2013;169:R1.PubMedCrossRefGoogle Scholar
  8. Arafah BM. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 1986;62:1173.PubMedCrossRefGoogle Scholar
  9. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000;85:1789.PubMedGoogle Scholar
  10. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab. 1997;82:82.PubMedGoogle Scholar
  11. Attanasio AF, Mo D, Erfurth EM, Tan M, Ho KY, Kleinberg D, Zimmermann AG, Chanson P. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab. 2010;95:74.PubMedCrossRefGoogle Scholar
  12. Bates AS, Van’t Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169.PubMedGoogle Scholar
  13. Baxter D, Sharp DJ, Feeney C, Papadopoulou D, Ham TE, Jilka S, Hellyer PJ, Patel MC, Bennett AN, Mistlin A, McGilloway E, Midwinter M, Goldstone AP. Pituitary dysfunction after blast traumatic brain injury: the UK BIOSAP study. Ann Neurol. 2013;74:527.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010;95:167.PubMedCrossRefGoogle Scholar
  15. Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab. 2000;85:970.PubMedGoogle Scholar
  16. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87:2067.PubMedCrossRefGoogle Scholar
  17. Birzniece V, Sata A, Ho KK. Growth hormone receptor modulators. Rev Endocr Metab Disord. 2009;10:145.PubMedCrossRefGoogle Scholar
  18. Bollerslev J, Ueland T, Jorgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P. Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency. Eur J Endocrinol. 2006;154:537.PubMedCrossRefGoogle Scholar
  19. Bonert VS, Elashoff JD, Barnett P, Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab. 2004;89:3397.PubMedCrossRefGoogle Scholar
  20. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthezene F. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab. 1999;84:1329.PubMedGoogle Scholar
  21. Brabant G, Poll EM, Jonsson P, Polydorou D, Kreitschmann-Andermahr I. Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations? Eur J Endocrinol. 2009;161(Suppl 1):S25.PubMedCrossRefGoogle Scholar
  22. Burman P, Mattsson AF, Johannsson G, Hoybye C, Holmer H, Dahlqvist P, Berinder K, Engstrom BE, Ekman B, Erfurth EM, Svensson J, Wahlberg J, Karlsson FA. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab. 2013;98:1466.PubMedCrossRefGoogle Scholar
  23. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998;83:382.PubMedCrossRefGoogle Scholar
  24. Cenci MC, Soares DV, Spina LD, de Lima Oliveira Brasil RR, Lobo PM, Mansur VA, Gold J, Michmacher E, Vaisman M, Conceicao FL. Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency. Pituitary. 2009;12:322.PubMedCrossRefGoogle Scholar
  25. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol. 2005;152:165.PubMedCrossRefGoogle Scholar
  26. Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest. 2004;113:25.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol. 2001;54:137.CrossRefGoogle Scholar
  28. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients – 2009 update. Endocr Pract. 2009;15(Suppl 2):1.PubMedCrossRefGoogle Scholar
  29. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, MacCario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol. 2005;153:257.PubMedCrossRefGoogle Scholar
  30. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992;37:387.CrossRefGoogle Scholar
  31. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 1998;83:107.PubMedGoogle Scholar
  32. Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony PD, On Behalf of the Kigs International Board. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr. 2006;95:1284.PubMedCrossRefGoogle Scholar
  33. Darzy KH. Radiation-induced hypopituitarism. Curr Opin Endocrinol Diabetes Obes. 2013;20:342.PubMedCrossRefGoogle Scholar
  34. Deodati A, Ferroli BB, Cianfarani S. Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis. Growth Horm IGF Res. 2014;24:105.PubMedCrossRefGoogle Scholar
  35. Diri H, Karaca Z, Simsek Y, Tanriverdi F, Unluhizarci K, Kelestimur F. Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults? Pituitary. 2015;18:884.PubMedCrossRefGoogle Scholar
  36. Diri H, Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Sheehan’s syndrome: new insights into an old disease. Endocrine. 2016;51:22.PubMedCrossRefGoogle Scholar
  37. Dusick JR, Wang C, Cohan P, Swerdloff R, Kelly DF. Pathophysiology of hypopituitarism in the setting of brain injury. Pituitary. 2012;15:2.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Elbornsson M, Gotherstrom G, Bosaeus I, Bengtsson BA, Johannsson G, Svensson J. Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol. 2013;168:745.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Elumir- Mamba LAS, Andag-Silva AA, Fonte JS, Mercado-Asis LB. Clinical profile and etiology of hypopituitarism at the University of Santo Tomas Hospital. Philipp J Intern Med. 2010;48:23.Google Scholar
  40. Fernandez-Rodriguez E, Lopez-Raton M, Andujar P, Martinez-Silva IM, Cadarso-Suarez C, Casanueva FF, Bernabeu I. Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients. Clin Endocrinol (Oxf). 2013;78:278.CrossRefGoogle Scholar
  41. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol. 1996;134:352.PubMedCrossRefGoogle Scholar
  42. Giavoli C, Libe R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A, Beck-Peccoz P. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab. 2004;89:5397.PubMedCrossRefGoogle Scholar
  43. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Salomon F, Sonksen PH, Russell-Jones D. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metab. 1999;84:2596.PubMedCrossRefGoogle Scholar
  44. Golgeli A, Tanriverdi F, Suer C, Gokce C, Ozesmi C, Bayram F, Kelestimur F. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan’s syndrome and effects of GH replacement therapy. Eur J Endocrinol. 2004;150:153.PubMedCrossRefGoogle Scholar
  45. Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera-Pombo JL, Vilardell E, Duran A, Mesa J, Faure E, Sanmarti A. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol. 2002;56:329.CrossRefGoogle Scholar
  46. Gotherstrom G, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson BA, Johannsson G, Svensson J. Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 2009;94:809.PubMedCrossRefGoogle Scholar
  47. Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. 2016;19:332.PubMedCrossRefGoogle Scholar
  48. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002;87:477.PubMedCrossRefGoogle Scholar
  49. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157:695.PubMedCrossRefGoogle Scholar
  50. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262.PubMedCrossRefGoogle Scholar
  51. Hoffman DM, O’Sullivan AJ, Freund J, Ho KK. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab. 1995;80:72.PubMedGoogle Scholar
  52. Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2048.PubMedCrossRefGoogle Scholar
  53. Holmes SJ, Shalet SM. Which adults develop side-effects of growth hormone replacement? Clin Endocrinol (Oxf). 1995;43:143.CrossRefGoogle Scholar
  54. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab. 1994;78:669.PubMedGoogle Scholar
  55. Ismailogullari S, Tanriverdi F, Kelestimur F, Aksu M. Sleep architecture in Sheehan’s syndrome before and 6 months after growth hormone replacement therapy. Psychoneuroendocrinology. 2009;34:212.PubMedCrossRefGoogle Scholar
  56. Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 1997;82:2877.PubMedGoogle Scholar
  57. Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol. 2010;162:453.PubMedCrossRefGoogle Scholar
  58. Karaca Z, Tanriverdi F, Dagli AT, Selcuklu A, Casanueva FF, Unluhizarci K, Kelestimur F. Three years prospective investigation of pituitary functions following subarachnoid haemorrhage. Pituitary. 2013;16:76.PubMedCrossRefGoogle Scholar
  59. Kelestimur F. Sheehan’s syndrome. Pituitary. 2003;6:181.PubMedCrossRefGoogle Scholar
  60. Kelestimur F. Chronic trauma in sports as a cause of hypopituitarism. Pituitary. 2005;8:259.PubMedCrossRefGoogle Scholar
  61. Kelestimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Koltowska-Haggstrom M, Goth MI. Sheehan’s syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in K. Eur J Endocrinol. 2005;152:581.PubMedCrossRefGoogle Scholar
  62. Kelestimur F, Popovic V, Leal A, Van Dam PS, Torres E, Perez Mendez LF, Greenman Y, Koppeschaar HP, Dieguez C, Casanueva FF. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test. Clin Endocrinol (Oxf). 2006;64:667.CrossRefGoogle Scholar
  63. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;93:743.PubMedCrossRefGoogle Scholar
  64. Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan C, Barkhoudarian G, Yuen KC, Guskiewicz K. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31:1161.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Klose M, Jonsson B, Abs R, Popovic V, Koltowska-Haggstrom M, Saller B, Feldt-Rasmussen U, Kourides I. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum – a KIMS analysis. Eur J Endocrinol. 2009;161(Suppl 1):S75.PubMedCrossRefGoogle Scholar
  66. Kokshoorn NE, Wassenaar MJ, Biermasz NR, Roelfsema F, Smit JW, Romijn JA, Pereira AM. Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values. Eur J Endocrinol. 2010;162:11.PubMedCrossRefGoogle Scholar
  67. Koller EA, Green L, Gertner JM, Bost M, Malozowski SN. Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients. J Clin Endocrinol Metab. 1998;83:2380.PubMedGoogle Scholar
  68. Koltowska-Haggstrom M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161(Suppl 1):S51.PubMedCrossRefGoogle Scholar
  69. Kovacs K. Sheehan syndrome. Lancet. 2003;361:520.PubMedCrossRefGoogle Scholar
  70. Kristjansdottir HL, Bodvarsdottir SP, Sigurjonsdottir HA. Sheehan’s syndrome in modern times: a nationwide retrospective study in Iceland. Eur J Endocrinol. 2011;164:349.PubMedCrossRefGoogle Scholar
  71. Kronvall E, Valdemarsson S, Saveland H, Nilsson OG. High prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a long-term prospective study using dynamic endocrine testing. World Neurosurg. 2015;83:574.PubMedCrossRefGoogle Scholar
  72. Lange M, Thulesen J, Feldt-Rasmussen U, Skakkebaek NE, Vahl N, Jorgensen JO, Christiansen JS, Poulsen SS, Sneppen SB, Juul A. Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol. 2001;145:147.PubMedCrossRefGoogle Scholar
  73. Lissett CA, Shalet SM. Effects of growth hormone on bone and muscle. Growth Horm IGF Res. 2000;10(Suppl B):S95.PubMedCrossRefGoogle Scholar
  74. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989;70:145.PubMedGoogle Scholar
  75. Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R, de Sanctis C, Gargantini L, Gastaldi R, Ghizzoni L, Secco A, Tinelli C, Ghigo E. Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol. 2005;152:589.PubMedCrossRefGoogle Scholar
  76. Maison P, Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation. 2003;108:2648.PubMedCrossRefGoogle Scholar
  77. Maison P, Griffin S, Beglah-Nicoue M, Haddad N, Balkau B, Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab. 2004;89:2192.PubMedCrossRefGoogle Scholar
  78. Malozowski S, Tanner LA, Wysowski D, Fleming GA. Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med. 1993;329:665.PubMedCrossRefGoogle Scholar
  79. Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De Marinis L, Giustina A. Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res. 2006;21:520.PubMedCrossRefGoogle Scholar
  80. McGauley GA, Cuneo RC, Salomon F, Sonksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res. 1990;33(Suppl 4):52.PubMedCrossRefGoogle Scholar
  81. Melmed S. Idiopathic adult growth hormone deficiency. J Clin Endocrinol Metab. 2013;98:2187.PubMedPubMedCentralCrossRefGoogle Scholar
  82. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1587.PubMedCrossRefGoogle Scholar
  83. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30:152.PubMedCrossRefGoogle Scholar
  84. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM. Influences on quality of life in GH deficient adults and their effect on response to treatment. Clin Endocrinol (Oxf). 1999;51:565.CrossRefGoogle Scholar
  85. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir (Wien). 2004;146:27.CrossRefGoogle Scholar
  86. Ozdogru I, Tanriverdi F, Dogan A, Kaya MG, Tugrul IM, Kalay N, Topsakal R, Unluhizarci K, Atmaca H, Kemal EN, Kelestimur F. Impaired longitudinal myocardial velocities in patients with growth hormone deficiency improves after hormone replacement therapy. J Am Soc Echocardiogr. 2007;20:1093.PubMedCrossRefGoogle Scholar
  87. Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet. 2000;356:1137.PubMedCrossRefGoogle Scholar
  88. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M, Beck-Peccoz P. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab. 2002;87:2042.PubMedCrossRefGoogle Scholar
  89. Qu XD, Gaw GI, Al Sayed MY, Cohan P, Christenson PD, Swerdloff RS, Kelly DF, Wang C. Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab. 2005;90:1563.PubMedCrossRefGoogle Scholar
  90. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55:735.CrossRefGoogle Scholar
  91. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285.PubMedCrossRefGoogle Scholar
  92. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 1993;129:195.Google Scholar
  93. Sartorio A, Ferrero S, Conti A, Bragato R, Malfatto G, Leonetti G, Faglia G. Adults with childhood-onset growth hormone deficiency: effects of growth hormone treatment on cardiac structure. J Intern Med. 1997;241:515.PubMedCrossRefGoogle Scholar
  94. Sassolas G, Chazot FB, Jaquet P, Bachelot I, Chanson P, Rudelli CC, Tauber JP, Allannic H, Bringer J, Roudaut N, Rohmer V, Roger P, Latapie JL, Reville P, Leutenegger M. GH deficiency in adults: an epidemiological approach. Eur J Endocrinol. 1999;141:595.PubMedCrossRefGoogle Scholar
  95. Schaefer S, Boegershausen N, Meyer S, Ivan D, Schepelmann K, Kann PH. Hypothalamic-pituitary insufficiency following infectious diseases of the central nervous system. Eur J Endocrinol. 2008;158:3.PubMedCrossRefGoogle Scholar
  96. Schneider HJ, Herrmann BL, Schneider M, Sievers C, Schaaf L, Stalla GK. Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury. Eur J Endocrinol. 2006;155:553.PubMedCrossRefGoogle Scholar
  97. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Hypopituitarism. Lancet. 2007a;369:1461.PubMedCrossRefGoogle Scholar
  98. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007b;298:1429.PubMedCrossRefGoogle Scholar
  99. Schneider HJ, Klotsche J, Wittchen HU, Stalla GK, Schopohl J, Kann PH, Kreitschmann-Andermahr I, Wallaschofski H. Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency. Clin Endocrinol (Oxf). 2011;75:825.CrossRefGoogle Scholar
  100. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med. 2000;133:111.PubMedCrossRefGoogle Scholar
  101. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalova J, Moshang T, Blum WF, Chipman JJ, Quigley CA, Attanasio AF. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab. 2003;88:4124.PubMedCrossRefGoogle Scholar
  102. Sheehan HL. Postpartum necrosis of the anterior pituitary. J Pathol. 1937;45:189.CrossRefGoogle Scholar
  103. Sheehan HL. The frequency of post-partum hypopıtuıtarısm. J Obstet Gynaecol Br Commonw. 1965;72:103.PubMedCrossRefGoogle Scholar
  104. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM. Mortality in patients with pituitary disease. Endocr Rev. 2010;31:301.PubMedCrossRefGoogle Scholar
  105. Simsek Y, Karaca Z, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F. A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders. Clin Endocrinol (Oxf). 2014;82:45.Google Scholar
  106. Stochholm K, Johannsson G. Reviewing the safety of GH replacement therapy in adults. Growth Horm IGF Res. 2015;25:149.PubMedCrossRefGoogle Scholar
  107. Stochholm K, Gravholt CH, Laursen T, Jorgensen JO, Laurberg P, Andersen M, Kristensen LO, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A. Incidence of GH deficiency – a nationwide study. Eur J Endocrinol. 2006;155:61.PubMedCrossRefGoogle Scholar
  108. Tanriverdi F, Kelestimur F. Pituitary dysfunction following traumatic brain injury: clinical perspectives. Neuropsychiatr Dis Treat. 2015;11:1835.PubMedPubMedCentralCrossRefGoogle Scholar
  109. Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome. Growth Horm IGF Res. 2005;15:231.PubMedCrossRefGoogle Scholar
  110. Tanriverdi F, Unluhizarci K, Coksevim B, Selcuklu A, Casanueva FF, Kelestimur F. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin Endocrinol (Oxf). 2007;66:360.CrossRefGoogle Scholar
  111. Tanriverdi F, Taheri S, Ulutabanca H, Caglayan AO, Ozkul Y, Dundar M, Selcuklu A, Unluhizarci K, Casanueva FF, Kelestimur F. Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: preliminary data. J Neurotrauma. 2008a;25:1071.PubMedCrossRefGoogle Scholar
  112. Tanriverdi F, Ulutabanca H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Three years prospective investigation of anterior pituitary function after traumatic brain injury: a pilot study. Clin Endocrinol. 2008b;68:573.CrossRefGoogle Scholar
  113. Tanriverdi F, Unluhizarci K, Kocyigit I, Tuna IS, Karaca Z, Durak AC, Selcuklu A, Casanueva FF, Kelestimur F. Brief communication: pituitary volume and function in competing and retired male boxers. Ann Intern Med. 2008c;148:827.PubMedCrossRefGoogle Scholar
  114. Tanriverdi F, De Bellis A, Teksahin H, Alp E, Bizzarro A, Sinisi AA, Bellastella G, Paglionico VA, Bellastella A, Unluhizarci K, Doganay M, Kelestimur F. Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? Pituitary. 2012;15:579.PubMedCrossRefGoogle Scholar
  115. Tanriverdi F, De Bellis A, Ulutabanca H, Bizzarro A, Sinisi AA, Bellastella G, Amoresano PV, Dalla ML, Selcuklu A, Unluhizarci K, Casanueva FF, Kelestimur F. A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity? J Neurotrauma. 2013;30:1426.PubMedCrossRefGoogle Scholar
  116. Tanriverdi F, Dokmetas HS, Kebapci N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database. Endocrine. 2014a;47:198.PubMedCrossRefGoogle Scholar
  117. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation. Endocrine. 2014b;47:679–89.PubMedCrossRefGoogle Scholar
  118. Tanriverdi F, Schneider HJ, Aimaretti G, Masel BE, Casanueva FF, Kelestimur F. Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev. 2015;36:305.PubMedCrossRefGoogle Scholar
  119. Theadom A, Starkey NJ, Dowell T, Hume PA, Kahan M, McPherson K, Feigin V. Sports-related brain injury in the general population: an epidemiological study. J Sci Med Sport. 2014;17:591.PubMedCrossRefGoogle Scholar
  120. Toogood AA, Ryder WD, Beardwell CG, Shalet SM. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol (Oxf). 1995;43:97.CrossRefGoogle Scholar
  121. Tsiakalos A, Xynos ID, Sipsas NV, Kaltsas G. Pituitary insufficiency after infectious meningitis: a prospective study. J Clin Endocrinol Metab. 2010;95:3277.PubMedCrossRefGoogle Scholar
  122. van Bunderen CC, van den Dries CJ, Heymans MW, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults. Eur J Endocrinol. 2014;171:151.PubMedCrossRefGoogle Scholar
  123. Vance ML. Hypopituitarism. N Engl J Med. 1994;330:1651.PubMedCrossRefGoogle Scholar
  124. Wilkinson CW, Pagulayan KF, Petrie EC, Mayer CL, Colasurdo EA, Shofer JB, Hart KL, Hoff D, Tarabochia MA, Peskind ER. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. Front Neurol. 2012;3:11.PubMedPubMedCentralCrossRefGoogle Scholar
  125. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res. 2001;16:398.PubMedCrossRefGoogle Scholar
  126. Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI, Bashir MI. Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril. 2005;84:523.PubMedCrossRefGoogle Scholar
  127. Zazryn TR, Finch CF, McCrory P. A 16 year study of injuries to professional kickboxers in the state of Victoria, Australia. Br J Sports Med. 2003;37:448.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Endocrinology and MetabolismErciyes University Medical SchoolKayseriTurkey

Personalised recommendations